Compare HAS & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HAS | ALGN |
|---|---|---|
| Founded | 1923 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 12.3B |
| IPO Year | N/A | N/A |
| Metric | HAS | ALGN |
|---|---|---|
| Price | $86.17 | $172.54 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 12 |
| Target Price | $90.70 | ★ $179.09 |
| AVG Volume (30 Days) | ★ 1.5M | 929.4K |
| Earning Date | 02-19-2026 | 02-04-2026 |
| Dividend Yield | ★ 3.25% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 5.16 |
| Revenue | ★ $4,357,000,000.00 | $3,982,622,000.00 |
| Revenue This Year | $10.19 | $2.58 |
| Revenue Next Year | $5.40 | $3.66 |
| P/E Ratio | ★ N/A | $33.22 |
| Revenue Growth | ★ 0.79 | 0.56 |
| 52 Week Low | $49.00 | $122.00 |
| 52 Week High | $89.20 | $237.23 |
| Indicator | HAS | ALGN |
|---|---|---|
| Relative Strength Index (RSI) | 58.07 | 69.29 |
| Support Level | $84.38 | $167.40 |
| Resistance Level | $87.38 | $174.01 |
| Average True Range (ATR) | 1.96 | 4.19 |
| MACD | 0.01 | 0.41 |
| Stochastic Oscillator | 60.13 | 90.48 |
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and since has divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022, offers the firm access to 19 million digital tabletop players.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.